Intermediate- and high-risk prostate cancer: a plea for high-dose, high-precision intensity-modulated radiotherapy with a modulated duration of androgen deprivation therapy
- PMID: 21944436
- DOI: 10.1016/j.eururo.2011.09.006
Intermediate- and high-risk prostate cancer: a plea for high-dose, high-precision intensity-modulated radiotherapy with a modulated duration of androgen deprivation therapy
Comment on
-
Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomes.Eur Urol. 2011 Dec;60(6):1133-9. doi: 10.1016/j.eururo.2011.08.029. Epub 2011 Aug 22. Eur Urol. 2011. PMID: 21889832 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
